The Drugs for Neglected Diseases initiative (DNDi), Siriraj Institute for Clinical Research (SICRES), and Siriraj Hospital, Mahidol University hosted the DNDi South-East Asia Strategic Plan Launch webinar “South-South Leadership: Working together on medical R&D to meet the needs of all patients, the example of dengue”.
Last year, DNDi launched a new Strategic Plan 2021-2028, charting a journey to deliver 15–18 treatments by 2028. South-East Asia is among the world’s most at-risk regions when it comes to the impact of global warming. The UN Intergovernmental Panel on Climate Change (IPCC) warned in its report that the region is facing rising sea levels, heat waves, droughts, and increasingly intense rainstorms.
In a world that is constantly changing, what can we do for neglected and vulnerable patients in South-East Asia? What is needed for R&D partnerships? How can we deliver on our commitments to people whose diseases have been historically overlooked by the traditional R&D model?
To mark the launch of our new strategy, we were joined by a panel of experts to explore what it will take to deliver medical solutions for neglected patients and build an R&D system that leaves no one behind.
Watch the recording
Agenda
| Opening – Jean-Michel Piedagnel, Regional Director, DNDi South-East Asia |
| Welcome address – Prof. Dr. Prasit Watanapa, M.D., Ph.D., Dean. Faculty of Medicine, Siriraj Hospital, Mahidol University |
| Special Address: The future of DNDi – turning the table around in R&D – putting the power of balance to endemic countries by Prof. Dr Suerie Moon MPA, PhD, Co-Director, Global Health Centre, Graduate Institute of International and Development Studies, Geneva and DNDi Board Director |
| Introduction of DNDi Strategic Plan – Dr Bernard Pécoul, Executive Director and Prince Mahidol Award Laureate |
| Dengue panel session: Co-ownership, co-funding, co-design of Dengue R&D programme with endemic countries Moderated by Prof. Dr Prasert Auwerakul, Siriraj Hospital, Thailand Panel: – Prof. Dr Pramod Kumar Garg, Executive Director, Translational health Science technology Institute (THSTI), India – Datuk Dr Shahnaz Murad, Technical Advisor, ProtectHealth Corporation, Ministry of Health, Malaysia – Prof. Dr Rosemary Sang, Chief Research Scientist, Kenya Medical Research Institute (KEMRI) and International Centre of Insect Physiology and Ecology (ICIPE), Kenya – Prof. Dr Marco Aurelio Krieger, Vice-President of Health Production and Innovation in Health, Fiocruz, Brazil – Dr Bernard Pécoul, Executive Director, DNDi – Dr Isabela Ribeiro, Viral Diseases Cluster Director, DNDi |
